Vipidia, analogues na kwayoyi na Rasha tare da farashin da sake dubawa

Vipidia (Allunan) Rating: 183

Mai masana'anta: Ana yin karin bayani
Siffofin Saki:

• Tab. 12.5 mg, 28 inji mai kwakwalwa,, Farashin daga 973 rubles
• Tab. 25 mg, 28 inji mai kwakwalwa., Farashin daga 1282 rubles

Farashin Vipidia a cikin kantin magani na kan layi
Umarnin don amfani

Vipidia shine wakili na hypoglycemic a cikin allunan tare da alogliptin. Yana ba da raguwa a cikin glycosylated haemoglobin da glucose. An nuna shi idan akwai nau'in ciwon sukari na 2 na mellitus a cikin hanyar monotherapy, kazalika a haɗuwa da jiyya tare da sauran wakilai na hypoglycemic. Mafi kyawun sashi shine 25 mg / rana, ana ɗauka komai abinci. Contraindicated a cikin ciwon sukari ketoacidosis, type 1 ciwon sukari mellitus, mai tsanani mai rauni zuciya, na koda da gazawar hanta. Abubuwan da ke tattare da cutarwa na iya haɗawa da ciwon kai, tashin hankali a cikin hanji, fitsari, cututtukan cututtuka na gabobin ENT. Ba a ba da umarnin ƙananan yara 'yan ƙasa da shekara 18 da mata masu juna biyu saboda rashin bayanai game da aikace-aikacen.

Analogs na miyagun ƙwayoyi Vipidia

Analog ne mai rahusa daga 863 rubles.

Mai masana'anta: Merck Sante SAA.S. (Faransa)
Siffofin Saki:

• Allunan 500 MG, 30 inji mai kwakwalwa., Farashin daga 110 rubles
• Allunan 1000 MG, 30 inji mai kwakwalwa., Farashin daga 185 rubles

Farashin Glucophage a cikin magunguna kan layi
Umarnin don amfani

Magungunan Faransa don maganin cututtukan type 2. Sanarwa a cikin allunan da ke kunshe daga 500 zuwa 1000 MG na metformin a matsayin babban sinadari mai aiki. Akwai contraindications, sabili da haka, kafin ɗaukar Glucofage, ya zama dole a nemi shawara tare da gwani.

Analog mai rahusa daga 182 rubles.

Mai masana'anta: Novartis (Switzerland)
Siffofin Saki:

• Allunan 50 MG, pcs 28., Farashin daga 791 rubles
• Allunan 1000 MG, 30 inji mai kwakwalwa., Farashin daga 185 rubles

Farashin Galvus a cikin kantin magani na kan layi
Umarnin don amfani

Galvus shiri ne na kwamfutar hannu don maganin nau'in mellitus na ciwon sukari na 2 dangane da vildagliptin a cikin sashi na 50 MG. Ana iya tsara shi duka biyu azaman maganin tauhidi kuma a matsayin ɓangaren haɗin magani idan akwai rashin ingancin abinci da motsa jiki.

Analog mai rahusa daga 795 rubles.

Mai masana'anta: Hemofarm A.D. (Serbia)
Siffofin Saki:

• Tab. 500 MG, pcs 60., Farashin daga 178 rubles
• Allunan 1000 MG, 30 inji mai kwakwalwa., Farashin daga 185 rubles

Farashin Metformin a cikin kantin magani na kan layi
Umarnin don amfani

Metformin magani ne na Serbian hypoglycemic don amfani na ciki. Abun da ke tattare da Allunan yana dauke da sinadaran aiki mai suna iri ɗaya a cikin adadin 500 ko 850 MG. An wajabta don maganin cututtukan type 2 (a cikin manya), musamman ma a cikin lokuta masu kiba.

Analog ya fi tsada daga 799 rubles.

Mai masana'anta: Bristol Myers Squibb (Amurka)
Siffofin Saki:

• Allunan 5 MG, pc 30., Farashin daga 1772 rubles
• Allunan 1000 MG, 30 inji mai kwakwalwa., Farashin daga 185 rubles

Farashi don Onglisa a cikin kantin magani na kan layi
Umarnin don amfani

Onglisa magani ne na Amurka don magance nau'in ciwon sukari na 2 na sukari dangane da saxagliptin a cikin sashi na 2.5 ko 5 mg. An wajabta shi ban da aikin jiki da rage cin abinci don inganta sarrafa glycemic.

Analog ya fi tsada daga 1236 rubles.

Mai masana'anta: Merck Sharp and Dome (Amurka)
Siffofin Saki:

• Allunan 100 MG, guda biyu., Farashin daga 2209 rubles
• Allunan 1000 MG, 30 inji mai kwakwalwa., Farashin daga 185 rubles

Farashin kuɗi don Januvia a cikin kantin magani na kan layi
Umarnin don amfani

Januvia magani ne na Americanan asalin Amurka don masu ciwon sukari. Sinadaran aiki: sitagliptin (a cikin nau'in phosphate monohydrate) 100 MG. Ana iya amfani dashi azaman ƙari ga aikin jiki da abinci don sarrafa sukari na jini.

Analog ya fi tsada daga 675 rubles.

Mai masana'anta: Beringer Ingelheim (Austria)
Siffofin Saki:

• Allunan 5 MG, pc 30., Farashin daga 1648 rubles
• Allunan 1000 MG, 30 inji mai kwakwalwa., Farashin daga 185 rubles

Farashi don Trazhenta a cikin kantin magani na kan layi
Umarnin don amfani

Trazhenta - wani magungunan Ostaraliya da aka yi niyya don magance cututtukan ciwon sukari na 2, ana iya sa shi duka biyu a matsayin maganin- kuma a matsayin ɓangaren haɗin maganin. Abinda ke aiki kawai a cikin abun da ke ciki shine linagliptin a cikin sashi na 5 MG. Ba a wajabta Trazenta don kamuwa da cututtukan type 1 ba, a lokacin daukar ciki, lactation, da kuma a cikin yara 'yan ƙasa da shekaru 18.

Vipidia: umarnin don amfani, farashi, sake dubawa da kuma alamun analogues

Vipidia magani ne wanda ake amfani dashi bisa ga umarnin don amfani da cutar sankara. Marasa lafiya tare da wannan ganewar asali ya kamata kula da glucose na jini koyaushe ta amfani da tsayayyen abincin, kuma idan bai isa ba, to magani.

Tsarin saki, abun da aka shirya da marufi

Magungunan an yi shi ne da nau'in allunan kwalaji mai rufi tare da membrane fim. Sashi:

• 12.5 MG - Allunan launin rawaya
• 25 MG - wani ɗan kwalliyar ja.

Ana sayar da samfurin a cikin fakitin kwali. Shiryawa: blister 4, mai dauke da allunan 7, jimlar 28 a cikin fakitin.

Abubuwan da ke aiki na miyagun ƙwayoyi shine alogliptin. Karin abubuwa:

• magnesium stearate,
• croscarmellose sodium
• microcrystalline cellulose,
• Hyprolose

Filin fim na kwamfutar hannu ya ƙunshi:

• sabbinne,
• baƙin ƙarfe oxide
• titanium dioxide
• macrogol
• launin toka mai launin F1

Ayyukan magunguna

Alogliptin wani inhibitor ne mai zaɓin dipeptidyl peptidase-4 sosai. DPP-4 shine babban enzyme wanda ke haifar da saurin lalacewar kwayoyin halittun da ke cikin iyali.

Musamman, shi ne polypeptide insulinotropic polypeptide (HIP) da glucagon-kamar peptide-1 (GLP-1). Ana samar da wadannan kwayoyin halittar a cikin hanji, kuma matakin su ya bambanta da abincin da aka ci.

Sakamakon HIP da GLP-1 an yi niyya don kunna ayyukan insulin kai tsaye a cikin ƙwayar cuta.

Peptide mai kama da Glucagon yana taimakawa rage yawan glucagon da rage jinkirin samar da glucose a cikin hanta.

Tare da kowane canje-canje a cikin matakin incretins a ƙarƙashin rinjayar alogliptin, haɓakar insulin yana ƙaruwa kuma glucagon yana raguwa tare da ƙara yawan sukari.

A cikin mutane masu ciwon sukari, irin waɗannan canje-canjen suna haifar da daidaituwa na gemocosylated haemoglobin da sauran ma'aunin jini kafin da bayan abinci.

Pharmacokinetics

Magungunan daidai suna shafar lafiyar mutum da haƙuri tare da ciwon sukari. Alogliptin yana cikin jiki kusan kashi 100%, komai girman abincin da aka cinye. Tare da kwamfutar hannu guda ɗaya, abu mai aiki yana ɗaukar hanzari cikin jini, inda bayan awa 1 zuwa 2 ana samun yawan ƙwayar magunguna.

Alogliptin yana da kyau a rarraba shi da kyau a kyallen takarda. Dangantaka da sunadaran plasma kusan 20-30%.

Tare da tsawanta yin amfani da miyagun ƙwayoyi, tarin abu mai aiki a cikin jikin mutum, bisa ga bayanan asibiti, ba a lura da lafiya ko marasa lafiya ba.

A tsakanin awanni 21 bayan shan maganin, kashi 70% na kayan yana cire ta ta hanyar da ba'a canza shi ba, 13% ta hanji.

Anyi maganin Vipidia don ciwon sukari na 2. Kayan aiki yana taimaka wa marasa lafiya yadda ya kamata, har ma da rashin bin ka'idodin abinci da rashin mahimmancin aikin jiki. Za'a iya amfani da maganin a matsayin monotherapy. Kuna iya sha shi tare da sauran magunguna waɗanda ke taimakawa rage yawan sukari a cikin jini.

Contraindications

Kamar kowane magani, Vipidia yana da iyaka. Karanta su a hankali.

Kada a bugu da miyagun ƙwayoyi tare da:

• hypersensitivity na jiki ga kowane abu da ke cikin miyagun ƙwayoyi,
• nau'in ciwon sukari guda 1
• mai ciwon sukari ketoacidosis,
• na kullum zuciya
• lalacewar hanta,
• ciki da lactation,
• yara ‘yan kasa da shekara 18.

Tare da taka tsantsan lokacin da:

• maganin cututtukan farji
• matsakaici na koda

Umarnin don amfani (sashi)

Ya kamata a sha Vipidia a baki, duka kafin kuma bayan abinci. An ba da shawarar yin amfani da ba fiye da 25 MG kowace rana. Wani lokaci ana tsara shi tare da wasu kwayoyi, kamar:

Tare da aikin haɗin gwiwa na Vipidia tare da metformin ko thiazolidinedione, kashi ɗin ya kasance canzawa. Don ware haɗarin hypoglycemia, lokacin da aka tsara maganin a lokaci guda tare da insulin, ya zama dole don rage sashi na ƙarshen. Idan saboda wasu dalilai kun manta shan shan maganin, kuna buƙatar gyara shi da sauri. Amma a lokaci guda kar a sha kashi biyu.

Side effects

Akwai wasu lokuta idan alamun rashin tausayi suka faru saboda maganin Vipidia. Mai haƙuri na iya yin gunaguni na:

• ciwon kai
• kamuwa da cutar huhu
• nasopharyngitis,
• zafi a ciki
• itching da fata tayi,
• cin gaban pancreatitis,
• da samuwar na koda gazawa.

Idan an gano irin waɗannan alamun tashin hankali, ya kamata ka sanar da likitanka. Zai iya yanke shawara don ci gaba da magani tare da miyagun ƙwayoyi ko a'a. Bayyananniyar bayyanar alamun alamun da ke sama na buƙatar cire maganin a cikin gaggawa.

Yawan abin sama da ya kamata

Yawan wuce haddi ba ya haifar da wata barazana ga mutane. Ana buƙatar taimakon likita ne kawai a lokuta idan ya kasance mai haƙuri ga Vipidia ko lokacin shan magunguna ta hanyar mutanen da ke fama da cututtukan da ke cikin jerin cututtukan contraindications. Taimako na farko don yawan abin sama da ya kamata - lavage na ciki.

Umarni na musamman

Amfani da jituwa na Vipidia tare da insulin da wasu magunguna waɗanda ke rage sukari jini yana buƙatar daidaita sashi don hana ci gaban hauhawar jini. Dangane da bincike na asibiti, hulɗa da alogliptin tare da wasu na'urorin lafiya bai nuna canje-canje da aka ambata ba.

Alogliptin yana shafar jikin sosai, saboda haka yayin jiyya ya kamata ka ƙi shan giya.

Magungunan "Vipidia" ba ya haifar da nutsuwa, don haka tuki da sauran ayyukan da ke buƙatar karuwar hankalin ne da yawa ba a haramta su ba.

Mahimmanci: binciken ya nuna cewa magani ba ya tasiri sosai a hanta, a ɗan karya ayyukansa. Har zuwa lokacin da muni zai iya faruwa. Sabili da haka, kafin amfani da maganin, ya zama dole a sami cikakken jarrabawa tare da kwatanta duk ribobi da mazan jiya.

Sakamakon karancin bayani game da mummunan yanayin yayin ciki da lactation, ya fi kyau kar a sha Vipidia.

Yara da tsufa

Bayar da magunguna ga yara da matasa masu shekaru 18 da suka wuce, yana sanadin rikice-rikice, saboda karancin bayanan asibiti a wannan zamani.

Marasa lafiya waɗanda shekarunsu suka wuce 60 na iya shan "Vipidiya". Ba a buƙatar amfani da maganin da aka saba koyaushe. Koyaya, yakamata a ɗauka a cikin zuciya cewa yiwuwar raguwar aikin kodan da hanta ya dogara da ƙayyadadden adadin ƙwayoyin cuta.

Sharuɗɗan da yanayin ajiya

Cire magani a cikin duhu, wuri mai sanyi daga yara. Maganar amfani shekaru uku ne daga ranar fitowa. Ranar da aka keɓance ranar haɗaɗɗiyar kayan aikin. An haramta amfani da miyagun ƙwayoyi.

Farashin Vipidia a cikin kantin magunguna ya bambanta da yawan magunguna da yankin zama. Matsakaicin, yana 845 - 1390 rubles.

Kwatanta tare da analogues

Idan saboda wasu dalilai magani bai dace da mai haƙuri ba, likita yana neman magani wanda za'a iya maye gurbinsa.

Jerin likitocin maganin "Vipidia":

Suna	Amfanin	Rashin daidaito	Farashi
Karin Galvus	Hanya mai tasiri don rage matakan sukari. Hakanan yana taimakawa kawar da karin fam ba tare da tilasta abinci ba.	Babban jerin tasirin sakamako masu illa. Babban farashin magunguna.	Daga 780 rubles.
Alogliptin	Yana taimakawa daidaitaccen matakan glucose. Ba ya haifar da haɓaka metabolism. Ba ya tara, gabaɗaya daga jikin.	Ba za a iya amfani da shi ba don cututtukan ƙwayoyin cuta na hanta, hanta, cututtukan fata. Magungunan ba su da arha.	Daga 845 rubles.
Januvia	Yana inganta rage nauyi, rage cin abinci, yana daidaita sigogin jini.	Kudin. Akwai magungunan hana haihuwa da yawa don amfani, saboda haka yana da mahimmanci likita ya wajabta maganin.	Daga 1350 rubles

Yawancin martani daga masu ciwon sukari da ke shan Vipidia suna da kyau. Waɗannan allunan yadda yakamata suna rage glucose jini, ana haƙuri da kyau, amma yakamata a yi amfani da shi kamar yadda likitan ya umurce shi. Mutane ba sa son gaskiyar cewa maganin yana da tsada. Ga wasu ra'ayoyi na gaske:

Na kamu da ciwon sukari shekaru 5 da suka gabata. An yi mata rajista tare da likitancin endocrinologist, ta sha kwayoyi da yawa. Amma 'yan makonnin da suka gabata, sukari ya fara tashi zuwa raka'a 18. Likita ya rubuta mani Vipidia. Na dauki kwamfutar hannu guda ɗaya kawai a rana, sukari daidai ne. Ina murna sosai. Ni da kaina na samu a cikin wannan maganin amfani guda ɗaya.

Vipidia yana maye gurbin insulin sosai. Kuma a kwatanta shi, maganin kawai yana buƙatar ɗauka sau ɗaya a rana. Ba lallai ba ne don adana abinci. Ina da ciwon sukari, allunan suna daidaita matakin glucose a cikin jini, don haka na riga na ƙi insulin na dogon lokaci. Gaskiya abun rikicewa ne game da farashin, magani ba shi da arha, ba kowa ne zai iya wadatar ba. Amma, ba shakka, akwai ƙari. Ina ba da shawarar shi ga kowa da kowa.

Ina da ciwon sukari na 2 Anyi mata magani, ta sha kwayoyi kullum, amma sai glucose din ya ragu, sannan kuma ya kara zuwa raka'a 12. Akwai lokuta na maganganu na hypoglycemic, raguwa mai ƙarfi na sukari.

Likita ya rubuta mani Vipidia. Na yi farin ciki da miyagun ƙwayoyi. Ina shan kwamfutar hannu guda kawai da safe kuma komai na al'ada. Kodayake yana da tsada, amma ban lura da sauyawa a cikin sigogi na jini ba kuma kwantar da hankalin kullun.

Likita ya ba ni takardar sayen magani don siyan maganin "Vipidia". Na kamu da ciwon sukari tsawon shekaru. Ina son maganin, yana rage alamomin glucose da kyau. Ina sha sau ɗaya kawai a rana.

Ba shi da contraindications lokacin hulɗa tare da wasu magunguna, wanda yake da kyau musamman. Ba ya cutar da kwakwalwa kuma baya haifar da nutsuwa. Ba a hana hawa mota tare da shi ba.

Na gamsu da komai, ingantaccen magani wanda bai haifar min da wata illa ba.

Allunan Vipidia - umarnin don amfani da magungunan analog

Cutar sankara (mellitus) cuta ce sananniya kuma mai haɗari. Marasa lafiya tare da wannan cutar yakamata a sanya idanu a kan sukarin jininsu a koyaushe tare da tsara shi da magani, in ba haka ba sakamakon zai iya zama mai m.

Abin da ya sa yana da matukar muhimmanci a san yadda magungunan da aka tsara don magance bayyanar cutar wannan aiki. Ofayansu shine Vipidia.

Bayanin magunguna gaba daya

Wannan kayan aikin yana nufin sabon ci gaba a cikin ilimin ciwon sukari. Ya dace da mutanen da ke dauke da cutar sankarau ta guda 2. Ana iya amfani da Vipidia duka biyu kuma a cikin haɗin tare da wasu magunguna na wannan rukunin.

Kuna buƙatar fahimtar cewa amfani da wannan magani ba tare da kulawa ba zai iya cutar da mai haƙuri, saboda haka dole ne a bi shawarar likita sosai. Ba za ku iya amfani da miyagun ƙwayoyi ba tare da yin rubutuna, musamman lokacin shan wasu magunguna.

Sunan kasuwanci na wannan magani shine Vipidia. A matakin kasa da kasa, ana amfani da sunan asalin Alogliptin, wanda ya fito daga babban bangaren aiki a tsarin sa.

Samfurin yana wakiltar samfurin samfurin allunan fim mai launi. Zasu iya zama launin rawaya ko mai haske mai haske (ya dogara da sashi). Kunshin ya hada da kwamfutoci guda 28. - 2 blister don allunan guda 14.

Formaddamar da tsari da abun da ke ciki

Akwai maganin Vipidia a cikin Ireland. Hanyar sakinsa shine Allunan. Suna da nau'i biyu, dangane da abun ciki mai aiki - 12.5 da 25 MG. Allunan tare da ƙaramin adadin kayan aiki suna da harsashi mai launin rawaya, tare da mafi girma - ja. A kowane ɓangare akwai rubutattun bayanai inda aka nuna adadinsu da mai ƙirar.

Babban sinadaran aiki na maganin shine Alogliptin Benzoate (17 ko 34 mg a cikin kowane kwamfutar hannu). Baya ga shi, an hada kayan taimako a cikin abun da ya kunsa, kamar:

• microcrystalline cellulose,
• mannitol
• Hyprolose
• sitiri na magnesium,
• croscarmellose sodium.

Abubuwa masu zuwa suna cikin murfin fim:

• titanium dioxide
• hypromellose 29104
• macrogol 8000,
• fenti rawaya ko ja (baƙin ƙarfe oxide).

Aikin magunguna

Wannan kayan aikin yana dogara ne akan Alogliptin. Wannan shine ɗayan sabbin abubuwa da ake amfani da su don sarrafa matakan sukari. Ya kasance ga yawan hypoglycemic, yana da tasiri mai ƙarfi.

Lokacin amfani da shi, akwai haɓakar ƙwayar insulin-glucose mai narkewa yayin rage glucagon samarwa idan aka ƙara yawan glucose jini.

Tare da nau'in ciwon sukari na 2, tare da hyperglycemia, waɗannan sifofin Vipidia suna ba da gudummawa ga irin waɗannan canje-canje masu kyau kamar:

• raguwa a cikin adadin haemoglobin (НbА1С),
• saukar da matakan glucose.

Wannan ya sa wannan kayan aiki ya zama mai tasiri wajen magance cutar sankaran siga.

Manuniya da contraindications

Magunguna waɗanda ke halayen babban ƙarfi suna buƙatar taka tsantsan a cikin amfani. Umarnin a gare su ya kamata a kiyaye su sosai, in ba haka ba maimakon fa'idodin jikin mai haƙuri zai cutar. Sabili da haka, zaka iya amfani da Vipidia kawai akan shawarar kwararre tare da kiyaye umarnin.

Ana bada shawarar kayan aiki don amfani da ciwon sukari na 2. Yana ba da ka'idoji da matakan glucose a cikin lokuta idan ba a yi amfani da maganin rage cin abinci ba kuma ba lallai ne ayyukan motsa jiki ba. Yi amfani da maganin sosai don maganin monotherapy. Hakanan ana ba da izinin amfani dashi tare da wasu magunguna waɗanda ke taimakawa rage matakan sukari.

Tsananta lokacin amfani da wannan maganin cutar sankarar mahaifa yana faruwa ne sanadiyyar kasancewar contraindications. Idan ba'a la'akari dasu ba, magani bazaiyi tasiri ba kuma yana iya haifar da rikitarwa.

Ba a yarda da Vipidia a cikin lamuran nan masu zuwa ba:

• mutum haƙuri da aka gyara zuwa ga miyagun ƙwayoyi,
• nau'in ciwon sukari guda 1
• tsananin rauni na zuciya
• cutar hanta
• mummunan lalacewar koda
• ciki da lactation,
• ci gaban ketoacidosis wanda ya haifar da ciwon sukari,
• Shekarun mai haƙuri har zuwa shekaru 18.

Wadannan take hakki sune tsauraran matakan kariya.

Hakanan akwai jihohi waɗanda aka rubuta maganin a hankali:

• maganin ciwon huhu
• na koda gazawar matsakaici mai ƙarfi.

Bugu da kari, dole ne a kula sosai lokacin da ake rubuta Vipidia tare da sauran magunguna don daidaita matakan glucose.

Side effects

Lokacin da ake kulawa da wannan magani, wasu lokuta alamu masu illa waɗanda ke alaƙa da sakamakon maganin suna faruwa:

• ciwon kai
• cututtuka na numfashi
• nasopharyngitis,
• ciwon ciki
• itching
• fata rashes,
• m pancreatitis
• cututtukan mahaifa
• ci gaban hanta gazawar.

Idan sakamako masu illa sun faru, nemi likita. Idan kasancewar su ba ta haifar da barazana ga lafiyar mai haƙuri, kuma karuwar su ba ta ƙaruwa ba, za a iya ci gaba da magani tare da Vipidia. Mummunan yanayin mai haƙuri yana buƙatar cire maganin kai tsaye.

Sashi da gudanarwa

Wannan maganin an yi shi ne don maganin baka. Ana yin lissafin sashi daban-daban, gwargwadon tsananin cutar, shekarun mai haƙuri, cututtukan haɗin da sauran abubuwan.

A matsakaici, ya kamata ya ɗauki kwamfutar hannu guda ɗaya wanda ya ƙunshi 25 MG na kayan aiki mai aiki. Lokacin amfani da Vipidia a cikin sashi na 12.5 MG, adadin yau da kullun shine Allunan 2.

An bada shawara don shan maganin sau ɗaya a rana. Shan kwayoyi ya kamata su sha duka ba tare da taunawa ba. A bu mai kyau ku sha su da ruwan zãfi. An yarda da karɓar karɓar abinci kafin da kuma bayan abinci.

Kada kayi amfani da kashi biyu na magani idan aka rasa kashi ɗaya - wannan na iya haifar da lalata. Kuna buƙatar ɗaukar kashi na yau da kullun na miyagun ƙwayoyi a cikin makusanci.

Shirye-shirye na irin wannan aiki

Duk da yake babu kwayoyi waɗanda zasu sami daidaituwa da tasiri iri ɗaya. Amma akwai kwayoyi waɗanda suke da kama da farashi, amma an ƙirƙira su daga wasu abubuwan da ke aiki waɗanda zasu iya yin aiki azaman analogues na Vipidia.

Wadannan sun hada da:

1. Januvia.Ya bada shawarar wannan maganin don rage sukarin jini. Abunda yake aiki shine sitagliptin. An wajabta shi a cikin maganganun guda ɗaya kamar Vipidia.
2. Galvus. Magunguna sun dogara da Vildagliptin. Wannan abu shine analog na Alogliptin kuma yana da kaddarorin iri ɗaya.
3. Janumet. Wannan magani ne wanda aka haɗu tare da tasirin hypoglycemic. Babban abubuwanda aka gyara sune Metformin da Sitagliptin.

Magunguna na iya ba da wasu magunguna don maye gurbin Vipidia. Sabili da haka, ba lallai ba ne don ɓoye wa likita mummunan canje-canje a cikin jikin da ke tattare da haɗarinsa.

Ra'ayoyin masu haƙuri

Daga sake dubawar marasa lafiya da ke shan Vipidia, ana iya kammala cewa allunan suna da kyau a haƙuri kuma suna taimakawa wajen riƙe da sukarin jini na yau da kullun, amma dole ne a ɗauka daidai gwargwadon umarnin, to sakamako masu illa suna da ɗanɗano kuma cikin sauri.

Abubuwan bidiyo akan abubuwan da ke haifar da, alamu da magani na ciwon sukari:

Kudin Vipidia na iya bambanta a cikin kantin magunguna a birane daban-daban. Farashin wannan magani a cikin sashi na 12.5 MG ya bambanta daga 900 zuwa 1050 rubles. Siyan magani tare da kashi 25 MG zai kara tsada - daga 1100 zuwa 1400 rubles.

Adana magungunan ya dogara da wuraren da ba su isa ga yara. Ba a yarda da hasken rana da danshi a kai ba. Yawan zazzabi kada ya wuce digiri 25. Shekaru 3 bayan fitarwa, ranar karewa na miyagun ƙwayoyi ta ƙare, wanda daga baya an haramta gudanar da mulkinta.

Muna bada shawara ga wasu labaran masu alaƙa

Vipidia: menene waɗannan kwayoyin magunguna kuma ta yaya zasu taimaka da ciwon sukari

Vipidia yana daya daga cikin magunguna masu yawa don maganin warkewar cutar siga mai nau'in 2. Ana iya amfani da shi duka daban-daban, wato, don maganin taɓotherapy, kuma a hade tare da wasu magunguna.

Abunda yake aiki - alogliptin, mallakar wani sabon ƙarni ne, yana wakiltar wani rukuni na incretin mimetics. Suna amsa gawar abinci ta hanyar inganta samar da insulin.

Allunan Vipidia don ciwon sukari suna da yawan kwalliya masu kyau, wanda saboda mahimmancin ingancin magani da tasiri ne.

Babban alamomi da contraindications

Abubuwan aiki mai aiki na Vipidia da aka zaɓa yana shafar dipeptidyl peptidase-4 (DPP-4). Analogs sau da yawa suna yin mummunan aiki, wanda aka nuna akan sakamakon magani.

Rayuwar shelf na wannan samfurin shine shekara uku, bayan wannan ba a ba da shawarar yin amfani da shi ba.

Ya kamata ku ajiye magungunan a wurin da ba shi da hulɗa da hasken rana, kuma zazzabi ba ya kai digiri 25.

Vipidia magani ne na kwamfutar hannu don rage sukarin jini. Ana amfani dashi wajen lura da ciwon sukari na 2.

An ba da shawarar fara shan shi lokacin da bin ka'idodin abinci tare da motsa jiki na motsa jiki ba su bayar da tasirin da ake so ba.

An ba shi izinin amfani dashi azaman ɓangare na monotherapy, magani mai rikitarwa tare da sauran magunguna masu cin abinci, kazalika da haɗuwa da insulin.

Akwai contraindications da yawa don shan wannan magani.

1. Kasancewar yanayin rashin lafiyan ko wani rashin hankali game da abu mai aiki ko abubuwan taimako na Vipidia.
2. Type 1 ciwon sukari.
3. Rashin rikice-rikice na metabolism metabolism - ketosis, m hyperglycemic state, hypoglycemia.
4. Ciwon zuciya
5. Tsarin cututtukan cututtukan hanta, tare da raunin aikinsa.
6. Cutar koda tare da gazawar koda.
7. Lokacin daukar ciki, lactation.
8. Hakanan an hana mutanen da shekarunsu bai kai 18 ba.

Tare da taka tsantsan kuma a ƙarƙashin kulawa ta fuskar likita, ana wajabta maganin idan mai haƙuri yana da muni ko ciwon mara, tare da ɗan raunin aikin koda da hanta. Lokacin amfani da Vipidia a matsayin wani ɓangare na ƙwayar jiyya tare da wasu kwayoyi, ya kamata a bincika hulɗarsu a hankali.

Karanta kuma Abin da kuke buƙatar sani game da lura da nau'in 1 da ciwon sukari na 2.

M sakamako masu illa

Lokacin shan wannan magani, wasu sakamako masu illa na iya haɓaka.

1. Tsarin juyayi yana ba da amsa tare da haɓakar ciwon kai.
2. Tsarin narkewa zai iya amsawa tare da bayyanar gastroesophageal reflux, jin zafi a cikin yankin na epigastric, haka kuma an lura da yawan cututtukan pancreatitis.
3. A wasu halaye, akwai keta alfarmar aiki na hanta, gall mafitsara.
4. Kumburi da oropharynx.
5. Effectsaya daga cikin mummunan sakamako masu illa na iya zama rashin lafiyar, wanda aka bayyana ta hanyar itching, Quincke's edema, urticaria.

Phenomena na anaphylaxis suna da wuya sosai, amma irin wannan damar na iya zama.

Idan zamuyi magana game da Vipidia tare da ido akan sake dubawar da marasa lafiyar da suka yi amfani da wannan magani, zamu iya yanke hukuncin cewa yana da tasiri sosai ga cututtukan type 2. Yana ba ku damar samun kyakkyawan sarrafawa game da cutar, kwantar da bayanin martaba na glycemic, rage glycosylated haemoglobin, yana nuna tasiri na kowane maganin warkewa.

Karanta shima .. Shin yana cutarwa ne saboda matsanancin ciwon sukari irin na 2

Wannan kayan aiki ne na musamman wanda ba shi da alamun analogues a cikin kayan sa har ila yau. Wannan shine, a cikin duniya babu wasu kwayoyi waɗanda babban kayan aikinsu shine alogliptin.

Koyaya, akwai wasu magunguna da yawa masu alaƙa da incretomimetics. An dauke su analogues na Vipidia, da kuma masu fafatawa a kasuwar magunguna. Mafi shahara da na kowa a cikin ƙasashe na iya zama.

Abubuwan da yake aiki shine sitagliptin. Ana bayar da maganin a cikin allunan, sigogi 25, 50, 100 milligrams. Yana da alamomi daidai da vipidia, yayin da kuma ana amfani dashi azaman ɓangare na monotherapy ko a hade tare da wasu jamiái.

Wannan shine cikakken shiri na Janavia, abun da ke ciki wanda ya ƙunshi Metformin. Maganin sitagliptin shine milligrams 50, metformin na iya zama cikin allurai uku - 500, 850 ko 1000 milligram.

Hakanan magani ne mai hade dangane da vildagliptin (wanda yake kama da alogliptin) tare da metformin. Dosages iri daya ne da na Yanumet.

Kawai. An yi shi ne a kan tushen sinadliptin mai aiki. Ta yanayinsa, ana ɗaukarsa mai lalata kayan haɗin gwiwa, wato, yana da tsarin aikin daban da na Vipidia, amma yana cikin rukuni ɗaya na kwayoyi. Dosages sune 2.5 da milligram 5.

Ciwan ComboGliz

Wannan magani ne mai haɗuwa wanda ya haɗa da saxagliptin tare da metformin. Yana da tasiri na tsawan lokaci saboda jinkirin sakin abubuwa masu aiki.

A yau, Vipidia shine sabon magani daga rukuni na incretin mimetics. Amfani da shi yana nuna sakamako mai kyau sosai, kuma farashin shi ya zama mai ma'ana, wanda ya haifar da gaskiyar cewa yawancin endocrinologists sun riga sun ɗauki wannan magani a cikin sabis.

Alamu don amfani

Vipidia magani ne na baki. An samar dashi a cikin nau'ikan allunan m na launin rawaya ko launin ja tare da bugawar kamfani da lambobin da ke gyara taro akan abu mai aiki.

An samar da miyagun ƙwayoyi a cikin nau'in Allunan, wanda aka tsara don zaɓuɓɓukan sashi 2:

• Allunan dake dauke da benlogate na inlogliptin - 12.5 MG, fentin rawaya,
• Allunan tare da abu mai aiki a cikin adadin 25 MG - a cikin ja.

Ana amfani da Vipidia don nau'in ciwon sukari na II na mellitus a matsayin magani mai zaman kanta ko tare da haɗin gwiwar wasu magunguna da ke nufin rage sukarin jini.

Abubuwan da ke aiki na miyagun ƙwayoyi shine sabon kayan aiki wanda ya danganci incretinomimetics. Manufar su shine ta motsa jiki don sakin insulin bayan cin abinci. Wannan rukuni na abubuwa kuma ya hada da polypeptide mai kama da glucose da polypeptide mai daukar nauyin glucose.

Ana bambanta Alogliptin ta hanyar zaɓin shi don enzyme dipeptidyl peptidase-4. Latterarshen na iya lalata hormones daga rukuni na masu haɗari tare da babban gudu. Ana iya haɗa su a cikin hanji kuma, yayin abinci, suna taimakawa ga samuwar insulin a cikin ƙwayar ƙwayar cuta.

Peptide mai kama da glucagon yana rage samarda glucagon, hakanan rage adadin glucose a hanta. Tare da karuwa a cikin adadin incretins, alogliptin yana ba da gudummawa ga haɓakar samar da insulin.

A lokaci guda, maida hankali na glucagon yana raguwa da tushen karuwa a matakin glucose a cikin jini. Wadannan hanyoyin suna haifar da raguwa a cikin adadin gemocosylated haemoglobin a cikin mutanen da ke fama da ciwon sukari marasa insulin.

Kari akan haka, matakan glucose na jini an saba sune duka a kan komai a ciki da kuma bayan jikewa.

Vipidia wakili ne na warkewa wanda ake amfani dashi don inganta yanayin mutanen da ke fama da ciwon sukari na II. Babban aikinta shine ƙara haɓaka aikin glucose.

Ana amfani da miyagun ƙwayoyi lokacin da aka sha shi a baki. Mafi kyawun kashi na warkewa shine 25 MG. Ana ɗaukar lokaci 1 kawai a rana. An hadar da kwamfutar hannu gaba ɗayanta kuma an wanke ta da ruwa tsarkakakken ruwa.

Idan hakan ta faru, to sai a ɗauki kashi biyu na yau da gobe ba zai yiwu ba. Furtheraddamar da gaba dole ne a aiwatar da yanayin da aka bada shawarar.

Idan ana amfani da Vipidia tare da metformin ko thiazolidinedione, to har yanzu ba zai yiwu a canza adadin magungunan da aka sha ba.

Canji na sashi zai iya faruwa ne kawai idan an yi amfani da miyagun ƙwayoyi tare da abubuwan da suka samo asali na sulfonylurea ko tare da insulin don rage yiwuwar cututtukan jini. Ana buƙatar kulawa ta musamman yayin jiyya tare da metformin da thiazolidinedione. Idan bayyanar cututtuka na hypoglycemia ya bayyana, ya kamata a rage yawan haɗarin metformin ko thiazolidinedione.

Ana nuna alamun Vipidia

Analogues na wani magani magunguna ne wanda ya ƙunshi abubuwa daban-daban na aiki, amma ana amfani dashi don magance cututtukan iri ɗaya tare da alamu guda.

Vipidia analogues masu dauke da tsarin alogliptin ba su wanzu ba tukuna. Koyaya, a cikin aikin warkewa, magunguna daga ƙungiyar incretin mimetics tare da abun da ya bambanta ana amfani dasu sosai. Wadannan sun hada da wadannan:

Irin waɗannan adadi masu yawa na analogues na nuna dacewar da mahimmancin magungunan wannan aikin. Nazarin game da Vipidia da yawancin magunguna masu kama da yawa galibi tabbatacce ne.

Matsalar kawai ita ce duk magungunan da ke daidaita abubuwan da ke tattare da sukari na jini a cikin ciwon sukari suna da yawa contraindications da sakamako masu illa.

Bugu da kari, aikace-aikacen su na bukatar sanin yanayin jikin mutum, kasancewar wasu cututtukan, sannan kuma yana bukatar sanya ido akai akai ba wai kawai sukarin jini ba, har ma da sauran alamu na jikin mutum.

Hypoglycemic miyagun ƙwayoyi, mai ƙarfi da kuma mai zaɓar mai hana mai ƙarfi na dipeptidyl peptidase-4 (DPP-4).

Zaɓin nata don DPP-4 ya fi sau 10,000 girma fiye da tasirin ta akan wasu enzymes masu alaƙa, gami da DPP-8 da DPP-9.

DPP-4 shine babban enzyme da ke haɗuwa da lalacewa cikin sauri na kwayoyin halittun da ke cikin iyali: glucagon-like peptide-1 (GLP-1) da polypeptide-insulinotropic-glucose-HIP).

Hormones na dangin ciki suna ɓoye a cikin hanji, ƙwaƙwalwar su tana ƙaruwa saboda martabar abinci. GLP-1 da HIP suna haɓaka aikin insulin da ɓoyewar sa by-sel.GLP-1 yana hana ɓoyewar glucagon kuma yana rage samarwa da glucose.

Saboda haka, ƙara yawan haɗuwar abubuwan haɗari, alogliptin yana ƙara yawan ɓoye-glucose mai narkewa na insulin kuma yana rage ɓoye glucagon tare da ƙara yawan glucose a cikin jini.

A cikin marasa lafiya da ke da nau'in ciwon sukari na 2 na cututtukan zuciya tare da hyperglycemia, waɗannan canje-canje a cikin ɓoye insulin da glucagon suna haifar da raguwa a cikin yawan ƙwayar glycosylated haemoglobin СbА1С da raguwa da yawaitar glucose a cikin jini na jini na duka azumi da kuma postprandial glucose.

Vipidia - umarnin don amfani, analogues

1 kwamfutar hannu 12.5 MG ya ƙunshi

Abunda yake aiki: alogliptin benzoate - 17 mg (cikin sharuddan alogliptin - 12.5 mg).

Abunda yake aiki: alogliptin benzoate - 34 MG (cikin sharuddan alogliptin -25 mg).

Fitowa:
Nucleus: mannitol 79.7 mg, microcrystalline cellulose 22.5 mg, hyprolose 4.5 mg, croscarmellose sodium 7.5 mg, magnesium stearate 1.8 mg.

Fim shafi: hypromellose 2910 5.34 mg, titanium dioxide 0.6 mg, iron dye oxide ja 0.06 MG, adadin macce-8000, launin launin toka mai F1 adadin 1.

Bayanin
Sashi 12.5 MG allunan biconvex mai launi, wanda aka rufe tare da shafi fim mai rawaya, tare da rubutun "TAK" da "ALG-12.5" a gefe guda.

Wakilin hypoglycemic shine dipeptidyl peptidase-4 inhibitor (DPP-4).

Pharmacodynamics

Alogliptin mai ƙarfi ne mai zaɓar mai hana DPP-4 ƙarfi sosai.

Zaɓin sa don DPP-4 ya fi sau 10,000 girma fiye da tasirin sa ga sauran enzymes masu alaƙa, gami da DPP-8 da DPP-9.

DPP-4 shine babban enzyme da ke haɗuwa da lalacewa cikin sauri na kwayoyin halittun da ke cikin iyali: glucagon-like peptide-1 (GLP-1) da polypeptide-insulinotropic-glucose-HIP).

Hormones na dangin ciki suna ɓoye a cikin hanji, ƙwaƙwalwar su tana ƙaruwa saboda martabar abinci. GLP-1 da HIP suna haɓaka aikin insulin da ɓoyewar shi ta ƙwayoyin beta na pancreatic. GLP-1 yana hana ɓoyewar glucagon kuma yana rage samarwa da glucose.

Saboda haka, ƙara yawan haɗuwar abubuwan haɗari, alogliptin yana ƙara yawan ɓoye-glucose mai narkewa na insulin kuma yana rage ɓoye glucagon tare da ƙara yawan glucose a cikin jini.

A cikin marasa lafiya da ke fama da nau'in ciwon sukari na 2 na cututtukan jini tare da hyperglycemia, waɗannan canje-canje a cikin ɓoye insulin da glucagon suna haifar da raguwa a cikin yawan ƙwayar glycosylated haemoglobin HbA1c da raguwa a cikin taro na glucose a cikin jini na jini na jini duka na azumi da kuma postprandial glucose.

Pharmacokinetics Magunguna na maganin alogliptin suna kama da mutane a cikin masu lafiya kuma a cikin marasa lafiya da ke ɗauke da ciwon sukari na 2.

Cikakken bayanin halitta na alogliptin kusan kashi 100% ne. Amfani da abinci mai ɗorewa tare da abinci mai-mai da yawa ba su shafi yankin a ƙarƙashin tsarin inlogliptin-lokaci ba, saboda haka ana iya ɗauka ba tare da la'akari da abincin ba. A cikin mutane masu lafiya, bayan gudanar da maganin guda ɗaya na har zuwa 800 MG na alogliptin, ana lura da saurin maganin tare da kai matsakaicin matsakaici (TCmax matsakaici.) A cikin kewayon daga 1 zuwa 2 hours daga lokacin gudanarwa. Babu masu ba da lafiya da masu haƙuri ko marasa lafiya da ke cikin nau'in ciwon sukari na 2 na sukari wanda ya nuna gagarumar tarin ƙwayar cuta alogliptin bayan maimaita aikin. AUC na alogliptin yana ƙaruwa daidai gwargwado tare da kashi ɗaya a cikin maganin warkewa daga 6.25 MG zuwa 100 MG. Bambanci na rarrabewar AUC na maganin rashin ƙarfi a cikin marasa lafiya yana da ƙananan (17%). AUC (O-inf) na alogliptin bayan kashi ɗaya ya kasance daidai da AUC (0-24) bayan ɗaukar wannan adadin sau ɗaya a rana don kwanaki 6. Wannan yana nuna rashin wadatar dogayen lokaci a cikin hanyoyin kwantar da hankali na tsarin alogliptin bayan an maimaita su.

Bayan gudanarwa guda ɗaya na maganin alogliptin a kashi 12.5 MG a cikin masu sa kai masu lafiya, ƙarar rarraba a cikin tashar tashar shine 417 L, wanda ke nuna cewa anlogliptin an rarraba shi sosai cikin kyallen takarda. Sadarwar tare da sunadaran plasma kusan 20-30%.

Alogliptin baya karkashin metabolism mai karfi, daga 60 zuwa 70% na alogliptin an cire shi da kodan.

Bayan gudanarwar 14C-wanda aka yiwa lakabi alogliptin a ciki, an ƙaddara manyan metabolites biyu: N-demethylated alogliptin, M-I (50 zuwa 30 zuwa 1/100, 1/1000, 1/10 000,